全文获取类型
收费全文 | 296篇 |
免费 | 12篇 |
国内免费 | 5篇 |
专业分类
儿科学 | 19篇 |
妇产科学 | 7篇 |
基础医学 | 14篇 |
口腔科学 | 8篇 |
临床医学 | 22篇 |
内科学 | 76篇 |
皮肤病学 | 11篇 |
神经病学 | 21篇 |
特种医学 | 45篇 |
外科学 | 38篇 |
综合类 | 8篇 |
预防医学 | 9篇 |
眼科学 | 3篇 |
药学 | 18篇 |
1篇 | |
肿瘤学 | 13篇 |
出版年
2021年 | 3篇 |
2020年 | 3篇 |
2019年 | 3篇 |
2018年 | 2篇 |
2017年 | 5篇 |
2016年 | 5篇 |
2015年 | 5篇 |
2014年 | 4篇 |
2013年 | 8篇 |
2012年 | 12篇 |
2011年 | 11篇 |
2010年 | 11篇 |
2009年 | 10篇 |
2008年 | 14篇 |
2007年 | 7篇 |
2006年 | 12篇 |
2005年 | 8篇 |
2004年 | 11篇 |
2003年 | 4篇 |
2002年 | 2篇 |
2001年 | 3篇 |
1999年 | 4篇 |
1998年 | 8篇 |
1997年 | 11篇 |
1996年 | 14篇 |
1995年 | 12篇 |
1994年 | 12篇 |
1993年 | 11篇 |
1992年 | 8篇 |
1991年 | 6篇 |
1990年 | 4篇 |
1989年 | 6篇 |
1988年 | 8篇 |
1987年 | 6篇 |
1986年 | 12篇 |
1985年 | 4篇 |
1984年 | 4篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1981年 | 6篇 |
1980年 | 5篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1975年 | 2篇 |
1973年 | 2篇 |
1971年 | 3篇 |
1969年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有313条查询结果,搜索用时 15 毫秒
11.
Early cerebral hyperglycolysis after subarachnoid haemorrhage correlates with favourable outcome 总被引:1,自引:0,他引:1
Cesarini KG Enblad P Ronne-Engström E Marklund N Salci K Nilsson P Hårdemark HG Hillered L Persson L 《Acta neurochirurgica》2002,144(11):1121-1131
Summary.
Background: Intracerebral microdialysis (MD) was applied in patients with severe subarachnoid haemorrhage treated in a neurosurgical
intensive care unit in order to explore their cerebral energy metabolism.
Method: Brain MD fluid levels of glucose, lactate and pyruvate were measured for 3 to 12 days in 20 patients and 2,635 hourly samples
were analysed. The MD data were related to computerized tomography and clinical outcome, assessed by the Glasgow Outcome Scale.
Findings: The study showed that most patients who made a good recovery had a specific curve pattern when plotting the studied metabolites
over time, characterised by a distinct decrease in MD-glucose and a parallel increase in both MD-lactate and pyruvate. Patients
who had an unfavourable outcome lacked this distinct curve pattern and exhibited more irregular changes, including increased
levels of both MD-glucose and lactate and low MD-pyruvate levels.
Interpretation: This exploratory study suggests that accumulation of interstitial lactate and pyruvate, together with decreasing levels of
glucose is a favourable prognostic pattern presumably reflecting increased glucose metabolism. Such hyperglycolysis may be
elicited in patients with recovery potential to cope with an extreme metabolic demand set in motion by a brain insult to restore
brain cell homeostasis and integrity.
Published online October 31, 2002
Acknowledgments The authors are grateful to Ms Karin Wettervik and Ms Monica Edberg for technical help. The study was supported by the Faculty
of Medicine, Uppsala University, the Swedish MRC (proj no. 7888), The Selander Foundation, The ?hlén Foundation and The King
Gustaf V and Queen Victoria's Foundation.
Correspondence: Dr. Lennart Persson, Department of Neurosurgery, Uppsala University Hospital, SE-751 85, UPPSALA, Sweden. 相似文献
12.
13.
Among the principal tenets of pediatric nutrition is the expectation that meeting the requirements for essential nutrients by feeding either artificial formulae or human milk results in indistinguishable physiological outcomes. This expectation has not been met. Were this observation confined to functional outcomes related to constituents of human milk not found in formula (e.g. immunological components, hormones and very-long-chain polyunsaturated fatty acids), differences between breast-fed and artificially fed infants would not be surprising. However, differences in growth between breast- and bottle-fed infants who live under favorable conditions were mostly unexpected. Bottle-fed infants demonstrate accelerated growth patterns compared to infants who are breast fed (1, 2). Similarly, differences between the growth of breast-fed infants and established growth references were not anticipated (2–4). 相似文献
14.
The prevalence of dyslipidaemia in children with insulin dependent diabetes mellitus (IDDM) and its relation to glycaemic control was studied in a group of 51 diabetic children and a control population of 132 schoolchildren. The prevalence of dyslipidaemia in the fasting state was increased in the diabetic group (39%) compared with control subjects (17%). Serum cholesterol concentration alone was raised in 25% of diabetic subjects while serum cholesterol and triglycerides were raised in 14%, compared with 16% and 0.7% respectively in control subjects. Serum total cholesterol (5.1 v 4.5 mmol/l), low density lipoprotein cholesterol (3.2 v 2.6 mmol/l), non-esterified fatty acids (0.91 v 0.50 mmol/l), and triglycerides (0.94 v 0.76 mmol/l) were higher in diabetic children. Serum total cholesterol, triglycerides, and apolipoprotein (apo)B concentrations increased with worsening control, while serum high density lipoprotein cholesterol and apoA-I concentrations were unaltered. There were also positive correlations between glycated haemoglobin and total cholesterol, triglycerides, and apoB in diabetic children. Thus, abnormalities in circulating lipids are common in young subjects with IDDM but largely disappear if blood glucose concentrations are reasonably controlled. 相似文献
15.
4-甲氧羰基-4-N-丙酰苯胺基哌啶1位衍生物的合成及其镇痛作用 总被引:2,自引:0,他引:2
本文报道了一系列N-[-1(2-苯乙基-4-甲氧羰基-4-哌啶基]-N-丙酰苯胺(4-甲氧羰基芬太尼)哌啶环1位取代衍生物的合成及其镇痛活性;讨论了结构与镇痛活性之间的关系。药理试验结果表明,大部分化合物具有典型的吗啡样镇痛活性,是一类作用极强的麻醉性镇痛剂。特别是哌啶环1位β-苯环被取代乙烯基替代的化合物具有相当或接近子母体化合物的镇痛活性。其代表物1321的镇痛活性(ED_(50)=0.005mg/kg ip,小鼠,热板法)略强于4-甲氧羰基芬太尼(ED_(50)=0.0063 mg/kg)。 相似文献
16.
Factor V Quebec revisited 总被引:2,自引:5,他引:2
Factor V Quebec has been described as a bleeding disorder that exhibits an autosomal dominant inheritance pattern and presents severe bleeding after trauma. Two members of a fourth-generation (IV.13 and IV.15) Canadian family have been studied in detail and are the subject of this report. Their clinical presentations and histories have been described previously (Tracy et al: J Clin Invest 74:1221, 1984). Persistent abnormalities include mild thrombocytopenia and defective platelet factor V. Plasma factor V is present at near normal concentration and is fully functional. Thus, the bleeding diathesis appears to reflect the absence of platelet factor V activity. The recent report (Hayward et al: Blood 84:110a, 1994 [suppl, abstr]) of multimerin deficiency in these individuals led us to reevaluate these patients. Western blot analyses of platelet lysates developed with a variety of monoclonal antibodies show that the alpha-granule proteins, fibrinogen, von Willebrand factor, factor V and osteonectin are decreased in concentration and significantly degraded in the platelets of these patients. Thrombospondin, while not degraded, is substantially decreased. In contrast, platelet factor 4 and beta-thromboglobulin do not appear to be affected. These observations suggest that the alpha- granules are correctly assembled but the contents are subsequently subjected to proteolytic degradation. The results indicate that factor V Quebec disorder is probably associated with a generalized defect that leads to degradation of most proteins of the alpha-granules. 相似文献
17.
K-Ⅱ系k阿片激动剂U-50488的同类物。通过部分离体和整体实验比较了K-Ⅱ与U-50488的药理作用。实验发现,K-Ⅱ抑制电刺激兔输精管收缩的IC50值为0.42 nmol/L,U-50488为26.5 nmol/L;K-Ⅱ抑制小鼠运动功能(横筛法)的ED50值为1.7 mg/g,U-50488为15.3 mg/kg;K-Ⅱ的小鼠LD50值为152.5 mg/kg,U-50488为118.4 mg/g;K-Ⅱ明显降低小鼠自发活动的作用比U-50488强5倍。结果表明,K-Ⅱ是一个药理作用较U-50488强的k受体激动剂。 相似文献
18.
Renzo Caprilli Monica Cesarini Erika Angelucci Giuseppe Frieri 《Journal of Crohn's and Colitis》2009,3(3):149-156
The advent of salicylates in the treatment of ulcerative colitis started in 1938 with the discovery of Salazopyrin by Nanna Svartz. This drug offered for the first time a therapeutic chance to patients with ulcerative colitis. In this paper we describe the fascinating history of Salazopyrin and salicylates from the first serendipitous observations to the last randomized clinical trials. Attention was paid to the pharmacokinetics and the mechanism of action of 5-aminosalicylates and, in particular, to the issue of the mucosal concentrations of 5-aminosalicylates and its therapeutic efficacy. Moreover a look at the new oral mesalazine formulations that allow the homogenous distribution of 5-aminosalicylate through all the large bowel was taken. Lastly, the possible use of mesalazine in the prevention of colorectal cancer was reviewed. 相似文献
19.